美国威尔医学院2018年招聘博士后职位(医学/ Heme-Onc方向)
POSTDOCTORAL POSITIONS (Medicine/ Heme-Onc)
POSTDOCTORALPOSITIONS
Hematology and Medical Oncology,Weill Medical College
Weill Cornell Medicine seeks 2 highly motivated professional PhDs for Postdoctoral positions in the Melnick lab.
Position 1:
To develop novel approaches for precision medicine immunotherapy approaches, using the tools of immunology and genomics. Skills in immunology and molecular biology are required.
Requirements: PhD degree with experience in standard and specialized laboratory skills including immunology, mouse models, and molecular biology and genetic systems such as CRISPR, shRNA, etc. Manuscript writing and presentations in meetings will be required.
Position 2:
To explore the interface between epigenetic mechanism, signaling pathways and cancer. Skills in epigenetic research, chromatin, biochemistry and genomic assays are required.
Requirements:PhD degree with experience in standard and specialized laboratory skills including epigenomic assays, comprehensive data analysis skills, manipulations of target gene expression using viral vectors, functional analyses in mouse disease model. Manuscript writing and presentations in meetings will be required.
The work will be performed under the supervision of Dr. Ari Melnick, Professor of Medicine. The applicants are expected to be independent thinkers with the highest professional skills.
The candidates should be self-motivated, with a proven track record of productivity. The applicants would be joining a highly supportive and interactive research team including cancer biologists, immunologists, hematopathologists, and computational biologists.
Appointments are for one year, with renewal based upon satisfactory performance and funding availability.
Excellent benefits package.
Please send your CV with 3 references to:
Attn: Ari Melnick, M.D.
E-MAIL: amm2014@med.cornell.edu
声明:凡本网注明"来源:XXX"的文/图等稿件,本网转载出于传递更多信息及方便产业探讨之目的,并不意味着本站赞同其观点或证实其内容的真实性,文章内容仅供参考。如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任。作者如果不希望被转载或者联系转载等事宜,请与我们联系。